Back to search
FDAFDA · Food and drugs·Recall number D-0487-2026

Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.

Published April 22, 2026 · Recall initiated: April 1, 2026

Summary

FDA records drug Class II recall D-0487-2026, published April 22, 2026 and initiated April 1, 2026. Recalling firm: Island Kinetics, Inc. d.b.a. CoValence Laboratories; Status: Ongoing; Reported quantity: 28,163 bottles; Lot: Lot#: 4228D2, 4229D1, Exp.: 07/31/2026 Lot#: 5147D2, Exp.: 04/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Island Kinetics, Inc. d.b.a. CoValence Laboratories
Distributor
U.S. Nationwide
Lot
Lot#: 4228D2, 4229D1, Exp.: 07/31/2026 Lot#: 5147D2, Exp.: 04/30/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9. recalled?

Yes. FDA published recall D-0487-2026 on April 22, 2026. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter